Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 2
2005 1
2006 1
2007 2
2008 1
2010 2
2011 3
2012 5
2013 3
2014 2
2015 5
2016 6
2017 3
2018 9
2019 4
2020 2
2021 3
2022 2
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

56 results

Results by year

Filters applied: . Clear all
Page 1
LINE-1-encoded reverse Transcriptase as a target in cancer therapy.
Sciamanna I, Sinibaldi-Vallebona P, Serafino A, Spadafora C. Sciamanna I, et al. Among authors: sinibaldi vallebona p. Front Biosci (Landmark Ed). 2018 Mar 1;23(7):1360-1369. doi: 10.2741/4648. Front Biosci (Landmark Ed). 2018. PMID: 29293438 Free article. Review.
Thymosin alpha 1 and HIV-1: recent advances and future perspectives.
Matteucci C, Grelli S, Balestrieri E, Minutolo A, Argaw-Denboba A, Macchi B, Sinibaldi-Vallebona P, Perno CF, Mastino A, Garaci E. Matteucci C, et al. Among authors: sinibaldi vallebona p. Future Microbiol. 2017 Feb;12:141-155. doi: 10.2217/fmb-2016-0125. Epub 2017 Jan 20. Future Microbiol. 2017. PMID: 28106477 Review.
Human endogenous retroviruses role in cancer cell stemness.
Matteucci C, Balestrieri E, Argaw-Denboba A, Sinibaldi-Vallebona P. Matteucci C, et al. Among authors: sinibaldi vallebona p. Semin Cancer Biol. 2018 Dec;53:17-30. doi: 10.1016/j.semcancer.2018.10.001. Epub 2018 Oct 11. Semin Cancer Biol. 2018. PMID: 30317035 Review.
Serum thymosin alpha 1 levels in normal and pathological conditions.
Pica F, Gaziano R, Casalinuovo IA, Moroni G, Buè C, Limongi D, D'Agostini C, Tomino C, Perricone R, Palamara AT, Sinibaldi Vallebona P, Garaci E. Pica F, et al. Among authors: sinibaldi vallebona p. Expert Opin Biol Ther. 2018 Jul;18(sup1):13-21. doi: 10.1080/14712598.2018.1474197. Expert Opin Biol Ther. 2018. PMID: 30063864 Review.
Thymosin α1 as a stimulatory agent of innate cell-mediated immune response.
Serafino A, Pierimarchi P, Pica F, Andreola F, Gaziano R, Moroni N, Zonfrillo M, Sinibaldi-Vallebona P, Garaci E. Serafino A, et al. Among authors: sinibaldi vallebona p. Ann N Y Acad Sci. 2012 Oct;1270:13-20. doi: 10.1111/j.1749-6632.2012.06707.x. Ann N Y Acad Sci. 2012. PMID: 23050812 Review.
Thymosin α1 and cancer: action on immune effector and tumor target cells.
Garaci E, Pica F, Serafino A, Balestrieri E, Matteucci C, Moroni G, Sorrentino R, Zonfrillo M, Pierimarchi P, Sinibaldi-Vallebona P. Garaci E, et al. Among authors: sinibaldi vallebona p. Ann N Y Acad Sci. 2012 Oct;1269:26-33. doi: 10.1111/j.1749-6632.2012.06697.x. Ann N Y Acad Sci. 2012. PMID: 23045967 Review.
Historical review on thymosin α1 in oncology: preclinical and clinical experiences.
Garaci E, Pica F, Matteucci C, Gaziano R, D'Agostini C, Miele MT, Camerini R, Palamara AT, Favalli C, Mastino A, Serafino A, Sinibaldi Vallebona P. Garaci E, et al. Among authors: sinibaldi vallebona p. Expert Opin Biol Ther. 2015;15 Suppl 1:S31-9. doi: 10.1517/14712598.2015.1017466. Epub 2015 Jun 22. Expert Opin Biol Ther. 2015. PMID: 26096345 Review.
56 results